This was one of the results about which I was most apprehensive, but while I don't think the quality of the result is all that flash, at least they haven't downgraded EBITDA outlook for FY25, which implies a 10% EBITDA growth.
But I'll wager no analysts have fully accounted for the interest expense line, which is surging - $65m in DY203 and $86m in JH25, for a total of $151m for FY24, and which is expected to rise by a further 25% in FY25.
It means that operating leverage benefits will be dampened and 10% EBITDA growth will probably only be matched at the bottom line.
But still, could have been worse.
.
This was one of the results about which I was most apprehensive,...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$27.16 |
Change
0.310(1.15%) |
Mkt cap ! $13.42B | |||
| Open | High | Low | Value | Volume |
| $26.99 | $27.50 | $26.80 | $22.89M | 842.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 620 | $27.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.17 | 23 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| SHL (ASX) Chart |